AddressBusiness: Piramal Critical Care
Department: Pharmacovigilance
Location: Kurla, Mumbai
Travel: Low
The Executive Pharmacovigilance will be responsible end-to-end case management, including case receipt, facilitation of case follow-up, case download from regulatory authority websites, database entry, peer review and submission to applicable regulatory authorities within stipulated timelines
- Good communication and interpersonal skills, both written and verbal
- Ability to manage multiple concurrent tasks
- Proven ability to meet strict deadlines
- Ability to work independently and in a team environment
- Competent in use of desktop applications: Microsoft word, excel and PowerPoint
- End-to-end case management, including case receipt, facilitation of case follow-up, case download from regulatory authority websites, database entry, peer review and
- submission to applicable regulatory authorities within stipulated timelines.
- Mailbox management and tracking of incoming Individual case safety reports (ICSRs). Reconciliation of ICSRs.
- Enter and/ or submit cases to applicable regulatory authority safety databases.
- Perform and monitor literature for company molecules.
- Maintain and update safety logs and safety files.
- Prepare and share compliance data with QPPV.
- Provide data for compliance representation/monthly information system.
- Assist in handling of product complaints and reconciliation.
- Assist in responding to queries and requests related to safety of products and Pharmacovigilance system from regulatory authorities.
- Prepare for internal or external audits and inspections.
- Preparation/Drafting of aggregate reports (PADER and PSURs).
- Coordination with different stakeholders for data request etc. for fulfilment of Pharmacovigilance responsibilities.
Piramal Critical Care (PCC), under Piramal Pharma Limited (PPL), a subsidiary of Piramal Enterprises Limited, is the third largest producer of Inhaled Anaesthetics and a global player in hospital generics. Motivated by its vision to deliver critical care solutions for patients and healthcare providers across the globe, PCC is committed to enabling sustainable and profitable growth for all its stakeholders.
PCC maintains a wide presence across the USA, Europe and more than 100 countries across the globe. Its rich product portfolio includes Inhalation Anaesthetics such as Sevoflurane, Isoflurane and Halothane as well as Intrathecal Baclofen therapy, for spasticity management. PCC has wholly-owned, state-of-the-art manufacturing facilities in the US and India that have successfully cleared periodical inspections by the US FDA, UK MHRA and other regulators.
Its core strength lies in a highly qualified global workforce of more than 400 employees across 16 countries. PCC is focused on further expanding its global footprint through new product additions in the critical care space.
Committed to corporate social responsibility alongside Piramal Group, PCC collaborates with various partner organizations and proudly takes an active role in providing hope and resources to those in need, as well as caring for the environment.
